Yıldız Aydın

856 total citations
39 papers, 176 citations indexed

About

Yıldız Aydın is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, Yıldız Aydın has authored 39 papers receiving a total of 176 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 17 papers in Genetics and 7 papers in Rheumatology. Recurrent topics in Yıldız Aydın's work include Chronic Lymphocytic Leukemia Research (16 papers), Chronic Myeloid Leukemia Treatments (13 papers) and Eosinophilic Disorders and Syndromes (7 papers). Yıldız Aydın is often cited by papers focused on Chronic Lymphocytic Leukemia Research (16 papers), Chronic Myeloid Leukemia Treatments (13 papers) and Eosinophilic Disorders and Syndromes (7 papers). Yıldız Aydın collaborates with scholars based in Türkiye, Australia and Vietnam. Yıldız Aydın's co-authors include Teoman Soysal, Ahmet Emre Eşkazan, Muhlis Cem Ar, Zafer Başlar, Ayşe Salihoğlu, Kadir Akan, Tuğrul Elverdi, Zafer Mert, Şeniz Öngören and Burhan Ferhanoğlu and has published in prestigious journals such as Blood, Journal of Hepatology and British Journal of Haematology.

In The Last Decade

Yıldız Aydın

36 papers receiving 168 citations

Peers

Yıldız Aydın
Yıldız Aydın
Citations per year, relative to Yıldız Aydın Yıldız Aydın (= 1×) peers M.‐J. Le Bris

Countries citing papers authored by Yıldız Aydın

Since Specialization
Citations

This map shows the geographic impact of Yıldız Aydın's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yıldız Aydın with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yıldız Aydın more than expected).

Fields of papers citing papers by Yıldız Aydın

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yıldız Aydın. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yıldız Aydın. The network helps show where Yıldız Aydın may publish in the future.

Co-authorship network of co-authors of Yıldız Aydın

This figure shows the co-authorship network connecting the top 25 collaborators of Yıldız Aydın. A scholar is included among the top collaborators of Yıldız Aydın based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yıldız Aydın. Yıldız Aydın is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aydın, Yıldız, et al.. (2024). Molecular Marker Applications in the Selection of Elite Genotypes for Plant Stress Tolerance and Genetic Fidelity. Marmara University Open Access System. 8(3). 1–25. 1 indexed citations
2.
Akkuş, Erman, Yıldız Aydın, Sevgi Kalayoğlu Beşışık, et al.. (2023). Germline genetic variants in Turkish familial multiple myeloma/monoclonal gammopathy of undetermined significance cases. British Journal of Haematology. 204(3). 931–938. 3 indexed citations
3.
Aydın, Yıldız, et al.. (2022). Molecular sexual determinants in Pistacia genus by KASP assay. Molecular Biology Reports. 49(6). 5473–5482. 7 indexed citations
4.
Öngören, Şeniz, Fevzi Yalniz, Dilek Keskin, et al.. (2022). Cytogenetic profile of adult AML patients in Turkey: a single center study with comprehensive comparison with literature. African Health Sciences. 22(3). 183–191.
5.
Eşkazan, Ahmet Emre, Dilek Keskin, Tuğrul Elverdi, et al.. (2021). Efficacy and Safety of Imatinib Treatment in Elderly Patients With Chronic Myeloid Leukemia: Real-Life Data and a Single-Center Experience. Clinical Lymphoma Myeloma & Leukemia. 21(8). 549–557. 6 indexed citations
6.
Soysal, Teoman, Ahmet Emre Eşkazan, Dilek Keskin, et al.. (2019). The Outcomes of Chronic Myeloid Leukemia Patients With Molecular Warning Responses During Imatinib Treatment According to the European LeukemiaNet 2013 Recommendations. Clinical Lymphoma Myeloma & Leukemia. 19(7). e377–e384. 2 indexed citations
7.
Öngören, Şeniz, Ayşe Salihoğlu, Ahmet Emre Eşkazan, et al.. (2018). Vincristine as an Adjunct to Therapeutic Plasma Exchange for Thrombotic Thrombocytopenic Purpura: A Single Institution Experience. Balkan Medical Journal. 35(6). 417–421. 5 indexed citations
9.
Yalniz, Fevzi, Ayşe Salihoğlu, Muhlis Cem Ar, et al.. (2017). Clinical Outcomes Related to the Use of Bendamustine Therapy for Multiple Myeloma Patients Relapsed-Refractory to IMiDs and Proteasome Inhibitors. Turkish Journal of Hematology. 34(3). 233–238. 2 indexed citations
10.
Eşkazan, Ahmet Emre, Mahir Cengız, Muhlis Cem Ar, et al.. (2016). Imatinib reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukaemia. Journal of Clinical Pathology. 69(9). 810–816. 3 indexed citations
11.
Sönmezoğlu, Kerim, Tuğrul Elverdi, Metin Halaç, et al.. (2016). The role of 68Ga-DOTA-TATE PET/CT scanning in the evaluation of patients with multiple myeloma. Nuclear Medicine Communications. 38(1). 76–83. 15 indexed citations
12.
Öngören, Şeniz, Ayşe Salihoğlu, Tuğrul Elverdi, et al.. (2015). IgD Multiple Myeloma, Descriptive Report of Eight Cases, Single Centre Experience. Clinical Lymphoma Myeloma & Leukemia. 15. e313–e313. 1 indexed citations
13.
Çetin, Güven, Ahmet Emre Eşkazan, Muhlis Cem Ar, et al.. (2014). Bone-Specific Alkaline Phosphatase Levels among Patients with Multiple Myeloma Receiving Various Therapy Options. Turkish Journal of Hematology. 31(4). 374–380. 1 indexed citations
14.
Aydın, Yıldız, et al.. (2013). Chromosomal location of genomic SSR markers associated with yellow rust resistance in Turkish bread wheat (Triticum aestivum L.). Journal of Genetics. 92(2). 233–240. 6 indexed citations
15.
Ar, Muhlis Cem, Nükhet Tüzüner, Ayşe Salihoğlu, et al.. (2013). Detailed Analysis of Diffuse Large B Cell Lymphoma Patients: A Single-Center, Retrospective Study. PubMed. 2013. 1–9. 6 indexed citations
16.
Eşkazan, Ahmet Emre, et al.. (2012). Successful Management of Chronic Refractory Immune Thrombocytopenia with Laparoscopic Splenectomy in a Patient with Acute Promyelocytic Leukemia. Indian Journal of Hematology and Blood Transfusion. 29(3). 173–177. 2 indexed citations
17.
Eşkazan, Ahmet Emre, Şeniz Öngören, Muhlis Cem Ar, et al.. (2011). Essential Thrombocythemia and Multiple Myeloma: Two Rare Diseases in One Patient. Clinical Lymphoma Myeloma & Leukemia. 11(5). 442–445. 9 indexed citations
18.
Ar, Muhlis Cem, Zafer Başlar, Teoman Soysal, et al.. (2009). The Effect of ZAP-70 Expression on Disease Progression in Early-Stage (Binet A) B-CLL Patients. Balkan Medical Journal. 2009(4). 317–321. 1 indexed citations
19.
Öngören, Şeniz, Muhlis Cem Ar, Ahmet Emre Eşkazan, et al.. (2009). Clonal Chromosomal Abnormalities in Philadelphia-Negative Cells and Their Clinical Significance in Patients with Chronic Myeloid Leukemia: Results of a Single Center. Turkiye Klinikleri Tip Bilimleri Dergisi. 29(2). 321–330. 1 indexed citations
20.
Aydın, Yıldız, et al.. (2004). Geriatrik hastalarda kas-iskelet sistemi hastalıkları. The Turkish Journal of Geriatrics. 7(4). 221–224. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026